Search Results - "Hagen, Volker A."

A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients: The RAMTAS trial of the German AIO (KRK-0316) by Kasper, Stefan, zur Hausen, Gerrit, Stein, Alexander, Stintzing, Sebastian, Berger, Andreas, Loges, Sonja, Hofheinz, Ralf, Trarbach, Tanja, Graeven, Ullrich, Fischer von Weikersthal, Ludwig, Goetze, Thorsten Oliver, Hagen, Volker A., Burock, Susen, Hoffmeister, Albrecht, Dechow, Tobias Nicolaas, Pauligk, Claudia, Virchow, Isabel, Siveke, Jens T, Al-Batran, Salah-Eddin, Schuler, Martin H.

“…Abstract only TPS3617 Background: Patients with metastatic colorectal cancer (mCRC) with progressive disease on/after or who are intolerant to…”
Get full text

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO by Hofheinz, Ralf, zur Hausen, Gerrit, Borchert, Kersten, Kretzschmar, Albrecht, Ebert, Matthias Philip, Ettrich, Thomas Jens, Koenigsmann, Michael, Haag, Georg Martin, Hagen, Volker A., Hoehler, Thomas, Homann, Nils, Kroening, Hendrik, Reichardt, Peter, Rieger, Michael, Teschendorf, Christian, Goekkurt, Eray, Lindig, Udo, Schmiegel, Wolff H., Pauligk, Claudia, Al-Batran, Salah-Eddin

“…Abstract only TPS4133 Background: Neoadjuvant or perioperative chemotherapy has become a standard of care for locally advanced, resectable gastric cancer and…”
Get full text